The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 32 results:
Author Title [ Type(Desc)] Year
Filters: Author is Konstas, Anastasios G P  [Clear All Filters]
Journal Article
Konstas, A. G. P., Voudouragkaki I. C., Boboridis K. G., Haidich A-B., Paschalinou E., Giannopoulos T., et al. (2014).  24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost.. Adv Ther. 31(6), 592-603.
Konstas, A. G. P., Topouzis F., Leliopoulou O., Pappas T., Georgiadis N., Jenkins J. N., et al. (2006).  24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma.. Ophthalmology. 113(5), 761-5.e1.
Katsanos, A., Gorgoli K., Mikropoulos D. G., Arranz-Marquez E., Athanasopoulos G. P., Teus M. A., et al. (2018).  Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma.. Expert Opin Biol Ther. 18(6), 719-724.
Holló, G., Kóthy P., & Konstas A. G. P. (2012).  Association of Cogan-Reese syndrome, exfoliation syndrome, and secondary open-angle glaucoma.. Eur J Ophthalmol. 22(1), 117-20.
Ritch, R., Prata T. S., de Moraes C. Gustavo V., Vessani R. M., Costa V. P., Konstas A. G. P., et al. (2010).  Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis.. Acta Ophthalmol. 88(1), 91-5.
Wirtz, M. K., Samples J. R., Toumanidou V., Charlesworth J., Mikropoulos D. G., Kaltsos K., et al. (2010).  Association of POAG risk factors and the Thr377Met MYOC mutation in an isolated Greek population.. Invest Ophthalmol Vis Sci. 51(6), 3055-60.
Quaranta, L., Katsanos A., Floriani I., Riva I., Russo A., & Konstas A. G. P. (2012).  Circadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucoma.. J Clin Pharmacol. 52(10), 1552-7.
Konstas, A. G. P., Holló G., Haidich A-B., Mikropoulos D. G., Giannopoulos T., Voudouragkaki I. C., et al. (2013).  Comparison of 24-hour intraocular pressure reduction obtained with brinzolamide/timolol or brimonidine/timolol fixed-combination adjunctive to travoprost therapy.. J Ocul Pharmacol Ther. 29(7), 652-7.
Boboridis, K. G., Uddin J., Mikropoulos D. G., Bunce C., Mangouritsas G., Voudouragkaki I. C., et al. (2015).  Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search.. Adv Ther. 32(7), 595-611.
Empeslidis, T., Banerjee S., Vardarinos A., & Konstas A. G. P. (2013).  Dexamethasone intravitreal implant for idiopathic retinal vasculitis, aneurysms, and neuroretinitis.. Eur J Ophthalmol. 23(5), 757-60.
Quaranta, L., Riva I., Mazziotti G., Porcelli T., Floriani I., Katsanos A., et al. (2014).  Elevated intraocular pressure in patients with acromegaly.. Graefes Arch Clin Exp Ophthalmol. 252(7), 1133-9.
Konstas, A. G. P., & Ringvold A. (2018).  Epidemiology of Exfoliation Syndrome.. J Glaucoma. 27 Suppl 1, S4-S11.
Liakopoulos, V., Demirtzi P., Mikropoulos D. G., Leivaditis K., Dounousi E., & Konstas A. G. P. (2015).  Erratum to: Intraocular pressure changes during hemodialysis.. Int Urol Nephrol. 47(10), 1691.
Boboridis, K. G., & Konstas A. G. P. (2018).  Evaluating the novel application of cyclosporine 0.1% in ocular surface disease.. Expert Opin Pharmacother. 19(9), 1027-1039.
Liakopoulos, V., Demirtzi P., Mikropoulos D. G., Leivaditis K., Dounousi E., & Konstas A. G. P. (2015).  Intraocular pressure changes during hemodialysis.. Int Urol Nephrol. 47(10), 1685-90.
Konstas, A. G. P., Tsironi S., Vakalis A. N., Nasr M. B., Stewart J. A., Nelson L. A., et al. (2009).  Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.. Acta Ophthalmol. 87(1), 71-6.
Mikropoulos, D., Mavrikakis I., Ziakas N. G., Konstas A. G. P., & Boboridis K. G. (2011).  Kaposi's Sarcoma of the Bulbar Conjunctiva in an Immunocompetent Patient.. Case Rep Ophthalmol. 2(2), 193-7.
Riva, I., Katsanos A., Floriani I., Biagioli E., Konstas A. G. P., Centofanti M., et al. (2014).  Long-term 24-hour intraocular pressure control with travoprost monotherapy in patients with primary open-angle glaucoma.. J Glaucoma. 23(8), 535-40.
Stewart, W. C., Konstas A. G. P., Kruft B., Mathis H. M., & Stewart J. A. (2010).  Meta-analysis of 24-h intraocular pressure fluctuation studies and the efficacy of glaucoma medicines.. J Ocul Pharmacol Ther. 26(2), 175-80.
Kymionis, G. D., Mikropoulos D. G., Portaliou D. M., Boboridis K. G., Voudouragkaki I. C., Dragoumis N. D., et al. (2014).  New perspectives on lamellar keratoplasty.. Adv Ther. 31(5), 494-511.
Konstas, A. G. P., Mikropoulos D. G., & Irkec M. (2010).  Open-angle glaucoma and ocular perfusion.. Br J Ophthalmol. 94(10), 1273-4.
Arranz-Marquez, E., Bolivar G., Piñero D. P., Konstas A. G. P., Mikropoulos D. G., & Teus M. A. (2013).  Orbscan topography in primary open-angle glaucoma.. Optom Vis Sci. 90(10), 1098-103.
Konstas, A. G. P., Quaranta L., & Realini T. (2012).  Overview of the [corrected] travoprost /timolol BAK-free fixed combination.. Expert Opin Pharmacother. 13(5), 757-66.
Konstas, A. G. P., Quaranta L., Mikropoulos D. G., Nasr M. B., Russo A., Jaffee H. A., et al. (2012).  Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma.. J Ocul Pharmacol Ther. 28(1), 26-32.
Tranos, P. G., Stavrakas P., Vakalis A. N., Asteriadis S., Lokovitis E., & Konstas A. G. P. (2015).  Persistent Subretinal Fluid After Successful Full-Thickness Macular Hole Surgery: Prognostic Factors, Morphological Features and Implications on Functional Recovery.. Adv Ther. 32(7), 705-14.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.